BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24266781)

  • 1. Non-traditional adipokines in pediatric HIV-related lipodystrophy: a-FABP as a biomarker of central fat accumulation.
    Theodoridou K; Margeli A; Spoulou V; Bathrellou I; Skevaki C; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Scand J Clin Lab Invest; 2014 Jan; 74(1):67-73. PubMed ID: 24266781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation.
    Morieri ML; Guardigni V; Sanz JM; Dalla Nora E; Soavi C; Zuliani G; Sighinolfi L; Passaro A
    BMC Infect Dis; 2018 Jan; 18(1):10. PubMed ID: 29304747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocytokines mark insulin sensitivity in euthyroid Hashimoto's patients.
    Solini A; Dardano A; Santini E; Polini A; Monzani F
    Acta Diabetol; 2013 Feb; 50(1):73-80. PubMed ID: 22639339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Lee HC; Kim JM
    Metabolism; 2009 Nov; 58(11):1523-9. PubMed ID: 19501863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and lipid profiles in HIV-infected Thai children receiving lopinavir/ritonavir-based highly active antiretroviral therapy.
    Dejkhamron P; Unachak K; Aurpibul L; Sirisanthana V
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):403-12. PubMed ID: 24259240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study.
    Piloya T; Bakeera-Kitaka S; Kekitiinwa A; Kamya MR
    J Int AIDS Soc; 2012 Jul; 15(2):17427. PubMed ID: 22814353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women.
    Choi KM; Kim TN; Yoo HJ; Lee KW; Cho GJ; Hwang TG; Baik SH; Choi DS; Kim SM
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):569-74. PubMed ID: 18710473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
    HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy.
    Landrø L; Damås JK; Flo TH; Heggelund L; Ueland T; Tjønnfjord GE; Espevik T; Aukrust P; Frøland SS
    Clin Exp Immunol; 2008 Apr; 152(1):57-63. PubMed ID: 18241231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: when children are not just "small adults".
    Kanaka-Gantenbein C; Margeli A; Pervanidou P; Sakka S; Mastorakos G; Chrousos GP; Papassotiriou I
    Clin Chem; 2008 Jul; 54(7):1176-82. PubMed ID: 18487287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
    Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
    Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy.
    Estrada V; Serrano-Ríos M; Martínez Larrad MT; Villar NG; González López A; Téllez MJ; Fernández C
    J Acquir Immune Defic Syndr; 2002 Jan; 29(1):32-40. PubMed ID: 11782587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study.
    Corripio R; Gónzalez-Clemente JM; Pérez-Sánchez J; Näf S; Gallart L; Nosàs R; Vendrell J; Caixàs A
    Eur J Endocrinol; 2010 Dec; 163(6):887-93. PubMed ID: 20870707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.
    Samaras K; Wand H; Law M; Emery S; Cooper DA; Carr A
    Curr HIV Res; 2009 Jul; 7(4):454-61. PubMed ID: 19601783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children.
    Viganò A; Mora S; Testolin C; Beccio S; Schneider L; Bricalli D; Vanzulli A; Manzoni P; Brambilla P
    J Acquir Immune Defic Syndr; 2003 Apr; 32(5):482-9. PubMed ID: 12679698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine.
    Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S
    Adv Med Sci; 2009; 54(2):221-4. PubMed ID: 19875355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases].
    Tao MM; Zhang L; Qiu ZF; Xie J; Han Y; Yu W; Li M; Li TS
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):867-71. PubMed ID: 19671283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.
    Milner KL; van der Poorten D; Xu A; Bugianesi E; Kench JG; Lam KS; Chisholm DJ; George J
    Hepatology; 2009 Jun; 49(6):1926-34. PubMed ID: 19475694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children.
    Sánchez Torres AM; Munoz Muniz R; Madero R; Borque C; García-Miguel MJ; De José Gómez MI
    Eur J Pediatr; 2005 May; 164(5):271-6. PubMed ID: 15650834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.